celecoxib has been researched along with bucladesine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Breyer, RM; Dannenberg, AJ; Du, B; Falcone, DJ; Khan, KM; Natarajan, C; Pavlovic, S; Sakamoto, K | 1 |
Amelinia, F; Fanoudi, S; Hashemzaei, M; Najafi, S; Nasiri, AA; Sanati, M; Shamshirgaran, F; Tabrizian, K | 1 |
3 other study(ies) available for celecoxib and bucladesine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages.
Topics: Animals; Blotting, Western; Bucladesine; Celecoxib; Cell Line; Colforsin; Cyclooxygenase 2; Extracellular Matrix; Gene Silencing; Macrophages; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Naphthalenes; Oligonucleotides; Peritoneum; Phenylbutyrates; Phosphorylation; Pyrazoles; Receptors, Prostaglandin E; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Sulfonamides; Time Factors; Transfection | 2006 |
Interactive involvement of hippocampal cAMP/PKA and cyclooxygenase-2 signaling pathways in spatial learning in the Morris water maze.
Topics: Animals; Bucladesine; Celecoxib; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Hippocampus; Isoquinolines; Male; Maze Learning; Protein Kinase Inhibitors; Rats; Rats, Wistar; Signal Transduction; Sulfonamides | 2018 |